GTCR and Gregory Lucier Form Corza Medical
Private equity firm
Surgical Specialties Corp. and the
TachoSil Fibrin Sealant Patch to create a new company called
Corza Medical.
Surgical Specialties is a medical technology company focused on surgical sutures and ophthalmic knives. TachoSil, previously owned by
Takeda Pharmaceutical Co. Ltd., is a surgical patch product line used to enable bleeding control during surgeries.
The company will be led by executive chairman Gregory Lucier and CEO
Dan Croteau, with a global team of over 1,700 employees supporting clinicians, distributors and medical device companies. Corza Medical will provide healthcare professionals a platform of surgical technologies with brands including
Charlesbank Buys Stake in MB2 Dental from Sentinel
Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant growth investment in
MB2 Dental, acquiring a majority interest from funds affiliated with
Sentinel Capital Partners and management.
Founded in 2007, MB2 Dental is a dental partnership organization with affiliated practices across 24 states. The remaining stake in MB2 is held by CEO and founder,
Dr. Chris Steven Villanueva, management and its doctor owners, who reinvested a substantial percentage of their equity.
Brandon White, managing director at Charlesbank, says, “We see significant M&A opportunity in the fragmented dental services market, and we believe that our investment will enable MB2 to accelerate its proven acquisition strategy as well as continue to develop its suite of shared services to support value creation.”